6th Dec 2007 13:09
Synexus Clinical Research PLC06 December 2007 For immediate release 6 December 2007 Synexus Clinical Research PLC (the "Company") Board changes and cancellation of AIM trading facility Further to the announcement earlier today by Sigma Acquisitions Ltd that itsoffer to acquire all of the Company's share capital, in issue or to be issued,is now unconditional in all respects, the Company has accepted the resignationsfrom the board of Malcolm Hughes and Ian Miscampbell with immediate effect. The Company has also made application to the London Stock Exchange to cancel itstrading facility on AIM with effect from 8.00am on 14 December 2007. For further enquiries: Paul McCluskey - Finance Director (01257 230723) Richard Evans - Brewin Dolphin Ltd, Nominated Adviser (0845 270 8600) ENDS This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Synectics